Jim Simons’s Windtree Therapeutics WINT Stock Holding History

Jim Simons’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,385	Closed	-$41.7K	–	3884
2024 Q4	$41.7K	Buy	+2,385	New	+$75.7K	﹤0.01%	3412
2023 Q1	–	Sell	-7	Closed	-$57K	–	4456
2022 Q4	$57K	Hold	7	–	–	﹤0.01%	3774
2022 Q3	$94K	Sell	7 -1	-13%	-$17.9K	﹤0.01%	3617
2022 Q2	$151K	Buy	8 +3	+60%	+$88.4K	﹤0.01%	3747
2022 Q1	$267K	Hold	5	–	–	﹤0.01%	3521
2021 Q4	$346K	Buy	5 +1	+25%	+$80K	﹤0.01%	3272
2021 Q3	$386K	Buy	4 +1	+33%	+$85.1K	﹤0.01%	2991
2021 Q2	$334K	Buy	+3	New	+$292K	﹤0.01%	3107
2021 Q1	–	Hold	0	–	–	–	3257

Other funds holding WINT

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jim Simons's WINT Position: Q1 2025 in Review

Jim Simons sold out of Windtree Therapeutics (WINT) in Q1 2025, closing a stake of 2,385 shares — an estimated $41.7K sold.

Jim Simons first reported a position in WINT in Q2 2021 and held it in 8 quarters. The position peaked at $386K in Q3 2021. 5 funds tracked by Wall St. Rank hold WINT as of Q1 2025.

Jim Simons reported no remaining Windtree Therapeutics position as of Q1 2025 after selling out during the quarter.
Jim Simons sold 2,385 Windtree Therapeutics shares in Q1 2025, an estimated $41.7K.
Jim Simons first reported a position in Windtree Therapeutics in Q2 2021 and held it in 8 quarters.
Jim Simons's Windtree Therapeutics position peaked at $386K in Q3 2021.
5 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.